Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.
Sign Up to like & getrecommendations! Published in 2018 at "American journal of preventive medicine"
DOI: 10.1016/j.amepre.2017.12.022
Abstract: At least 2.3 million people in the U.S. have an opioid use disorder, less than 40% of whom receive evidence-based treatment. Buprenorphine used as part of medication-assisted treatment has high potential to address this gap… read more here.
Keywords: workforce; use; treatment; workforce barriers ... See more keywords